Schneidewind L, Drager DL, Rossberg V, Nolting J, et al. Prospective Evaluation of Health-Related Quality of Life in Patients with Metastatic Urothelial Carcinoma Undergoing Immunotherapy with Pembrolizumab: Symptom Burden Can Predict Survival. Urol Int 2023;107:80-86.
PMID: 36244329